<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl3" position="float"><object-id pub-id-type="doi">10.7554/eLife.13135.009</object-id><label>Table 3.</label><caption><p>Details of patient samples tested.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13135.009">http://dx.doi.org/10.7554/eLife.13135.009</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Group</th><th valign="top">Clinical signs</th><th valign="top">Sample type (number of samples)</th><th valign="top">Collection dates</th><th valign="top">Collection locations</th><th valign="top">Mean age in years (range)</th><th valign="top">95% CI (years)</th><th valign="top">Sex ratio</th><th valign="top">Test used</th><th valign="top">Number (proportion) of positive</th></tr></thead><tbody><tr><td valign="top">1</td><td valign="top">Dengue-like/ influenza-like illness</td><td valign="top">Acute and convalescent sera (n=510 including 98 acute, 214 convalescent and 198 paired sera)</td><td valign="top">2005-2010</td><td valign="top">Kampong Cham, various</td><td valign="top">11.0 <break/>(4 months to 70 years)</td><td valign="top">10.0-12.0</td><td valign="top">0.44</td><td valign="top">IgG ELISA</td><td valign="top">89 (17.4%) <break/>- Acute sera: 33 (33.7%) <break/>- Convalescence sera: 25 (11.7%) <break/>- Paired sera: 31 (15.7%) with evidence of seroconversion in 7 pairs (3.5%)</td></tr><tr><td valign="top">2</td><td valign="top">Healthy individuals (community dengue seroprevalence study)</td><td valign="top">Sera (n=529)</td><td valign="top">2009</td><td valign="top">Kampong Cham</td><td valign="top">10.0 (1 month-20 years)</td><td valign="top">9.59-10.42</td><td valign="top">0.50</td><td valign="top">IgG ELISA</td><td valign="top">70 (13.23%)</td></tr><tr><td valign="top">3</td><td valign="top">Meningo-encephalitis</td><td valign="top">Cerebrospinal fluid (n=200<sup>&#163;</sup>)</td><td valign="top">2013-2014</td><td valign="top">Various</td><td valign="top">6.5 (3 months-15 years)</td><td valign="top">5.95-7.06</td><td valign="top">0.40</td><td valign="top">Real Time RT-PCR</td><td valign="top">0 (0%)</td></tr><tr><td valign="top">4</td><td valign="top">Dengue-like febrile illness</td><td valign="top">Sera collected during febrile stage (n=253*)</td><td valign="top">2009, 2011-2013</td><td valign="top">Various</td><td valign="top">8.2 <break/>(1 to 38 years)</td><td valign="top">7.6-8.8</td><td valign="top">0.48</td><td valign="top">Semi-nested RT-PCR</td><td valign="top">0 (0%)</td></tr><tr><td valign="top">5a</td><td valign="top">Influenza-like illness (negative for four common respiratory viruses)</td><td valign="top">Nasopharyngeal swabs (n=328)</td><td rowspan="2" valign="top">2007-2012</td><td rowspan="2" valign="top">Various</td><td rowspan="2" valign="top">13.2 <break/>(1 month to 83 years)</td><td rowspan="2" valign="top">12.0-14.4</td><td rowspan="2" valign="top">0.51</td><td rowspan="2" valign="top">Semi-nested RT-PCR</td><td valign="top">4 (1.2%)</td></tr><tr><td valign="top">5b</td><td valign="top">Influenza-like illness (positive for four common respiratory viruses)</td><td valign="top">Nasopharyngeal swabs (n=392<sup>#</sup>)</td><td valign="top">0 (0%)</td></tr><tr><td valign="top">6</td><td valign="top">Acute lower respiratory infection</td><td valign="top">Nasopharyngeal swabs (n=279<sup>$</sup>)</td><td valign="top">2008-2009</td><td valign="top">Various</td><td valign="top">2.7 <break/>(7 months to 63 years)</td><td valign="top">2.1-3.4</td><td valign="top">0.41</td><td valign="top">Semi-nested RT-PCR</td><td valign="top">2 (0.7%)</td></tr><tr><td valign="top">7</td><td valign="top">Healthy individuals (H5N1 contacts) &#8211; negative control</td><td valign="top">Nasopharyngeal swabs (n=266<sup>&#167;</sup>)</td><td valign="top">2005-2011</td><td valign="top">Various</td><td valign="top">29.3 <break/>(1 to 79 years)</td><td valign="top">27.1-31.5</td><td valign="top">0.45</td><td valign="top">Semi-nested RT-PCR</td><td valign="top">0 (0%)</td></tr><tr><td valign="top">8</td><td valign="top">Healthy anti-rabies vaccination volunteers &#8211; negative control</td><td valign="top">Nasopharyngeal swabs (n=238<sup>&#165;</sup>)</td><td valign="top">2013</td><td valign="top">Institute Pasteur Cambodia (Phnom Penh)</td><td valign="top">26.7 <break/>(9 months to 83 years)</td><td valign="top">24.5-28.8</td><td valign="top">0.56</td><td valign="top">Semi-nested RT-PCR</td><td valign="top">0 (0%)</td></tr></tbody></table><table-wrap-foot><fn id="tblfn2"><p>CI = Confidence Interval</p></fn><fn id="tblfn3"><p><sup>&#163;</sup> 3 no information on age; * 8 no information on age and sex; <sup>#</sup> 2 no information on age and sex; <sup>$</sup> 1 no information on age; <sup>&#167;</sup> 5 no information on age and sex; 51 no information on sex; <sup>&#165;</sup> 5 no information on age and sex</p></fn></table-wrap-foot></table-wrap>